COVID-19 and Myositis: What We Know So Far
COVID-19와 근염: 우리가 지금까지 알고 있는 것
Review
[키워드] ACE2
adaptive
Angiotensin-converting enzyme
Autoimmunity
back pain
Care
Clinical presentations
COVID-19
dermatomyositis
diagnostic
disease
Elevation
enzyme
greater
idiopathic
Idiopathic inflammatory myopathy
immune activation
Immunopathogenesis
Immunosuppression
Inflammation
Inflammatory
Invasion
Logistic
manifestation
marker
Myasthenia
myositis
pandemic
Patient
recent
reported
researcher
rhabdomyolysis
rheumatologist
similarity
Tele-triage
Telemedicine
the mean
therapeutic
Therapeutic strategies
Treatment
triggered
unique
with COVID-19
[DOI] 10.1007/s11926-021-01023-9 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s11926-021-01023-9 PMC 바로가기 [Article Type] Review